题名 | Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study |
链接 | http://www.sciencedirect.com/science/article/pii/S147020451170184X |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |